The TAGGS Assistance Listing Report provides detailed award information for a single Assistance Listing. The data provided is from FY 2008 or from the start date of data collection through the present. For information prior to FY 2008, please use the TAGGS Advanced Search.
In the top display you will see the name of the Assistance Listing, agency, assistance type, and any popular name it might use, along with the 5-digit CFDA number.
Assistance Listings consisting of Direct Payment Awards may not contain links to additional recipient and award information. Direct Payment data is often collected as aggregated payments to a state to protect the personal information of the assistance recipients.
Along with the bar chart broken up by Issue Date or Funding Fiscal Year, there is also an exportable table below that groups by Issue Date or Funding Fiscal Year and shows the recipient name, state, award number, award title and amount from each award action.
By using the radio buttons, you may view data by the Issue Date Fiscal Year of by Funding Fiscal Year. In most cases, the Issue Date and Funding Fiscal Years coincide, although in some cases, delays in issuing an award and award close outs will cause the Issue Date of an award to be outside the of the Funding Fiscal Year.
Table data can be exported by choosing one of the export-format icons located at the top right of the table. Export file formats include:
The two Fiscal Year (FY) viewing options are:
|Issue Date FY||The FY in which the award action Occurred|
|Funding FY||The FY in which the award action Funded|
To enter Keyboard Support and Web Page Reader Support for the report results grid view, you will need to press Ctrl Shift G
|Move through rows||← ↑ ↓ →|
|Next page||SHIFT PAGE DOWN|
|Previous page||SHIFT PAGE UP|
|Move through column headers and data fields||TAB|
|Sort ASC/DESC when a column header is selected||ENTER|
Objectives: The National Institute of and Musculoskeletal and Skin Diseases (NIAMS) mission is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; training of basic and clinical scientists to carry out this research; and dissemination of information on research progress in these diseases. The Extramural Program promotes and supports basic, translational, and clinical studies of Systemic Rheumatic and Autoimmune Diseases, Skin Biology and Diseases, Bone Biology and Diseases, Muscle Biology and Diseases, and Joint Biology and Diseases and Orthopaedics. NIAMS Systemic Rheumatic and Autoimmune Diseases programs address basic, translational, and clinical research, including clinical trials and observational and mechanistic studies, focused on immune-mediated arthritis and autoimmune-related acute and chronic disorders in adults and children. NIAMS Skin Biology and Diseases programs support basic, translational, and clinical research in skin, including both common and rare skin diseases. These programs include investigations of the basic molecular, cellular, and developmental biology of skin, as well as studies of skin as an immune, sensory, endocrine, and metabolic organ. NIAMS Bone Biology and Diseases programs support research on the control of bone formation, resorption, and mineralization as well as the effects of signaling molecules on bone cells. They support clinical studies of interventions to prevent fractures associated with osteoporosis and research into less common bone diseases. NIAMS Muscle Biology and Diseases programs encourage research on muscle developmental biology, growth, maintenance, and hypertrophy; physiology of contraction; structural biology of the contractile apparatus; disease mechanisms; biomarkers and outcome measures; and development and clinical testing of therapies for conditions including the muscular dystrophies. NIAMS Joint Biology, Diseases, and Orthopaedics programs support a broad spectrum of research centered on the interplay among the body’s muscles, bones, and connective tissues. They encourage tissue engineering and regenerative medicine research, molecular biology, imaging, and clinical research, and the treatment and prevention of orthopaedic conditions. NIAMS participates in the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The SBIR program is intended to increase private sector commercialization of innovations derived from Federal research and development; to increase small business participation in Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation. The STTR program is intended to stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions; to foster technology transfer between small business concerns and research institutions; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation of socially and economically disadvantaged small business concerns and women-owned small business concerns in technological innovation.